TransCode Therapeutics, Inc. Profile Avatar - Palmy Investing

TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage produc…

Biotechnology
US, Boston [HQ]

News

Theses · Events · Sentiments
End of RNAZ's Analysis
CIK: 1829635 CUSIP: 89357L105 ISIN: US89357L3033 LEI: - UEI: -
Secondary Listings
RNAZ has no secondary listings inside our databases.